Sleiman El Jamal, M.D.

Vascular Neurologist, and Neurohospitalist. Published information represent my views only and does not constitute any medical advice.

[Shadi Yaghi @ShadiYaghi2]

A breakthrough in secondary prevention. Asundexian reduced ischemic stroke risk without increased bleeding. Congratulations to Mike Sharma and @Ash_Shoamanesh and the OCEANIC-STROKE team. Well done 👏 #ISC26

[Sleiman El Jamal, M.D. @sleiman_jamal]

Excellent Fireside Chats about Small Aneurysm Controversies by the experts at #ISC26. This session highlighted the importance of close follow up when managing this disease with uncertain prognosis and limited data. @AANmember
@svinsociety @ShadiYaghi2 @StrokeAHA_ASA @AHAScience

[Johanna Seiden, MD MPH @JohannaSeidenMD]

What's New in IVT? Relative and Absolute Contraindications #ISC26 @StrokeAHA_ASA

[Sleiman El Jamal, M.D. @sleiman_jamal]

Excellent session about Cancer and Stroke at #ISC26 discussing the granularity of decision making despite the paucity of available clinical data! @AANmember @ShadiYaghi2 @svinsociety @StrokeAHA_ASA

[Sleiman El Jamal, M.D. @sleiman_jamal]

IA tPA after EVT resulted in higher probability of an excellent 90 day outcome comp with standard medical therapy after MT in patients with LVO in the anterior circulation within 24 hr with a good safety profile #PeARL trial
@StrokeAHA_ASA @AANmember
@svinsociety @JayDoliaMD

[Sleiman El Jamal, M.D. @sleiman_jamal]

Patients with AIS within 12 hrs due to Medium Vessel Occlusion (MeVO), EVT +BMT did not show improvement in clinical outcomes #ESCAPEMeVo Trial.

@StrokeAHA_ASA @AANmember @svinsociety @JayDoliaMD @DiogoHaussen @ShadiYaghi2 @BrownNeurology @elghanemmoh

#ISC25

[Sleiman El Jamal, M.D. @sleiman_jamal]

EVT plus Beat Medical Therapy did not result in a reduction of disability or death compared to BMT alone without any excess Harm- #DISTALtrial

@StrokeAHA_ASA @JayDoliaMD @DiogoHaussen @AANmember
@svinsociety @BrownNeurology @elghanemmoh @ShadiYaghi2

#ISC25

[Sleiman El Jamal, M.D. @sleiman_jamal]

Dr. Sleiman El Jamal https://t.co/DWIQUudsVb via @YouTube
Proud to be a @WCMQatar Alum!
@cpd_wcmq @TArayssi

[Sleiman El Jamal, M.D. @sleiman_jamal]

That’s a wrap! #ISC 24- see you in LA next year! @StrokeAHA_ASA @svinsociety

[Stroke AHA/ASA @StrokeAHA_ASA]

🧵#ISC24 Results from the multi-center STOP-CAD study: Exploring cervical artery dissection #CAD treatments, anticoagulation vs. antiplatelet therapy reveals a trend toward lower ischemic stroke risk with anticoagulation, mainly in those with occlusive disease.

[Sleiman El Jamal, M.D. @sleiman_jamal]

Exciting results from the STOP-CAD (anticoagulation vs antiplatelets in cervical artery dissection) study by @ShadiYaghi2 et al…..#ISC24 @StrokeAHA_ASA @AANmember @JayDoliaMD @Nirav_r_bhatt @EricGoldsteinMD @LiqiShu @EmoryStroke @BrownNeurology @NeuroIntervener @DiogoHaussen

[Shadi Yaghi @ShadiYaghi2]

#ISC24 Final results STOP-CAD in patients with cervical artery dissection are out. Anticoagulation with non-significantly lower ischemic stroke risk but higher bleeding risk if cont’d up to 180 days. Occlusive dissections did better with anticoagulation. https://t.co/noJdoQr775

[Shadi Yaghi @ShadiYaghi2]

#ISC24 Final results STOP-CAD in patients with cervical artery dissection are out. Anticoagulation with non-significantly lower ischemic stroke risk but higher bleeding risk if cont’d up to 180 days. Occlusive dissections did better with anticoagulation. https://t.co/noJdoQr775

[Sleiman El Jamal, M.D. @sleiman_jamal]

Excellent discussions about Stroke Outcomes in the young in addition to some sequelae that may not be often recognized: mental health issues, sexual dysfunction, return to work/driving, etc…#ISC24 @StrokeAHA_ASA @AANmember @ShadiYaghi2 @svinsociety @Nirav_r_bhatt @LiqiShu

[Sleiman El Jamal, M.D. @sleiman_jamal]

Hello Phoenix ! Happy 100th to the AHA @StrokeAHA_ASA @AANmember #ISC24

[Sleiman El Jamal, M.D. @sleiman_jamal]

Who knew? MT is safe and effective in middle income countries using CT/CTA without advanced imaging in the Extended window up to a certain age-RESILIENT-Extend trial #ISC24 @StrokeAHA_ASA @AANmember @DiogoHaussen @JayDoliaMD @Nirav_r_bhatt @rangarajulab @ShadiYaghi2

[Sleiman El Jamal, M.D. @sleiman_jamal]

Should Antiplatelet monotherapy be the Standard care for ESUS? Or are there more tailored approach? What about the risks of bleeding with anticoagulation and DAPT? Innovative debates #ISC24 @JayDoliaMD @StrokeAHA_ASA @AANmember @ShadiYaghi2 @niravbhatt1234 @LiqiShu @DiogoHaussen

[Sleiman El Jamal, M.D. @sleiman_jamal]

Should Loop Recorders be the standard of Care? Does SCAFDAS (subclinical AF detected after stroke) need to be treated? What about other wearables that could replace ILRs?Hello #ISC24 debates @StrokeAHA_ASA @svinsociety @AANmember @JayDoliaMD @ShadiYaghi2 @LiqiShu

[Sleiman El Jamal, M.D. @sleiman_jamal]

Should ESUS be retired? Are we lumping many etiologies in one? Interesting debate in #ISC24 @StrokeAHA_ASA @ArKatsanos @hoomankamel @ShadiYaghi2 @svinsociety @JayDoliaMD

[Sleiman El Jamal, M.D. @sleiman_jamal]

@elghanemmoh @svinsociety Congratulations!

[Stroke: Vascular and Interventional Neurology @SVINJournal]

Carotid Webs typically lead to cortical strokes and are often associated with large vessel occlusions! Check out the recent paper about infarct patterns in this condition.
@sleiman_jamal @DiogoHaussen @GradyHealth @PerrydaCamaraMD @jwallen_neuro

https://t.co/TpvJCFq2io